# Serological Response to Retreatment of Serofast Early Syphilis Cases With Benzathine Penicillin

> **NCT02884115** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Syphilis

## Interventions

- **DRUG:** benzathine penicillin

## Key facts

- **NCT ID:** NCT02884115
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02884115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02884115, "Serological Response to Retreatment of Serofast Early Syphilis Cases With Benzathine Penicillin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02884115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*